ArticleBreast cancer research : BCR2014

A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes.

Richard Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.